Cedilla Therapeutics

About:

Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.

Website: https://www.cedillatx.com

Top Investors: Eli Lilly, RA Capital Management, Woodline Partners, Boxer Capital, Third Rock Ventures

Description:

Cedilla is a developer of therapeutics technologies intended to broaden the reach of small molecule therapeutics. The company's technology is focused on destabilizing oncoprotein targets that are also applicable to therapies outside of oncology, enabling doctors to treat diseases caused by protein dysregulation. The company was founded in 2018 and based in Cambridge, Massachusetts.